Cyient Ltd provided an update on April 30, 2026, regarding its proposed ₹720 crore equity share buyback, first announced on April 23, 2026. The company reiterated that securing approval from the U.S. Securities and Exchange Commission (SEC) remains a critical step before the buyback can proceed.
This requirement for U.S. SEC approval arises because the company has U.S. resident shareholders. Their holdings trigger complex regulatory demands due to differing legal frameworks between India and the United States concerning tender offer buybacks. To navigate these cross-border rules, Cyient confirmed it will submit an application to the U.S. SEC seeking exemptive relief on certain tender offer procedures.
The board of Cyient had approved the buyback plan on April 23, 2026. The proposal involves repurchasing up to 6.4 million shares at ₹1,125 per share, marking the company's first buyback since 2019. The initial filing had already indicated the need to seek U.S. SEC exemptive relief, and today's clarification confirms this regulatory process is actively underway.
For investors, this means the buyback's execution is contingent on obtaining specific U.S. SEC approval. The review process could introduce delays, potentially extending the buyback timeline and creating uncertainty. Shareholders are advised to closely monitor official company communications for progress updates. While Cyient's strategic initiatives remain, the capital return program faces this regulatory gateway.
The primary risk is any complication or delay in obtaining the necessary exemptive relief from the U.S. SEC. Navigating these conflicting regulatory requirements can prolong the approval period. This operating environment, marked by regulatory complexity, is not entirely new for Cyient. The company previously faced a U.S. IRS penalty in May 2025, which reported no material impact, and saw a 'no-poach' lawsuit against a former executive dismissed, though a related civil suit continues.
Other major Indian IT firms, such as Infosys, have successfully obtained similar exemptive relief from the U.S. SEC for their buyback programs, setting a precedent. Companies like TCS, Wipro, and Tata Technologies also operate within a similar sector, where regulatory hurdles for cross-border corporate actions are a known factor.
Investors should closely watch Cyient's application for exemptive relief with the U.S. SEC and any updates provided by the company. The finalization of the buyback offer period and subsequent shareholder communications will depend on the SEC's response. Management commentary during future earnings calls will also be key in understanding the regulatory process.
